A Study of LY3437943 in Japanese Participants With Type 2 Diabetes Mellitus (T2DM)

NCT04823208 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

64

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG: LY3437943
DRUG: Placebo

Sponsor

Eli Lilly and Company